Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
BioCubaFarma is responsible for over 60% of Cuba’s essential medicines list. The portfolio includes internationally marketed prophylactic and therapeutic vaccines (including a COVID-19 vaccine and cancer immunotherapies), biosimilars, and biopharmaceuticals that have demonstrated significant impact in public health and are exported to more than 40 countries[1][2][3][5].
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on BioCubaFarma.